The IEHP Pharmacy Academic Detailing team is an educational and evidence-based outreach program for our providers and pharmacies. We perform phone and one-on-one outreaches with physicians, nurse practitioners, physician assistants, and pharmacy staff. Our goal is to transform the prescriber and pharmacy practice and enhance the provider, pharmacist and member experience.
Clinical Drug Education
Clinical Drug Education provides materials that focus on a specific drug, drug class, and/or disease state. These materials contain pharmacological and clinical practice information to assist providers and pharmacies in their practice. As new drug information is available, it is important to stay up to date on clinical research findings to assist with member care and medication-use decisions.
Practice Development
Practice development education provides materials that focus on enhancing provider and member experience. The materials contain guidance on Formulary Utilization and PA submissions as well as insights regarding electronic prescribing and electronic health records. It is our commitment to provider practice optimization tools and resources to enhance member care.
Biosimilars
A growing trend in healthcare is the use of biosimilar drugs. The following information will assist you and your practice on prescribing biosimilars.
- What is a Biosimilar? (PDF) Download What is a Biosimilar? (PDF)
- Biosimilars: Are They the Same Quality? (PDF) Download Biosimilars: Are They the Same Quality? (PDF)
- Biological Product Definitions (PDF) Download Biological Product Definitions (PDF)
- Prescribing Biosimilar Products (PDF) Download Prescribing Biosimilar Products (PDF)
- Prescribing Interchangeable Products (PDF) Download Prescribing Interchangeable Products (PDF)
Opioid and Chronic Pain Management
In collaboration with Riverside University Health System (RUHS) and Centers for Disease Control and Prevention (CDC), IEHP would like to provide the following information to assist you and your practice on prescribing opioids for chronic pain management.
- CURES FAQ (PDF) Download CURES FAQ (PDF)
- CURES 2.0 User Guide (PDF) Download CURES 2.0 User Guide (PDF)
- CURES tips and tricks (PDF) Download CURES tips and tricks (PDF)
- Naxolone Drug facts (PDF) Download Naxolone Drug facts (PDF)
- Naxolone instructions for use (PDF) Download Naxolone instructions for use (PDF)
- First Responder Naxolone administration fact sheet (PDF) Download First Responder Naxolone administration fact sheet (PDF)
- Medication Assisted Treatment (MAT) and Opioid Treatment Program (OTP) FAQ (PDF) Download Medication Assisted Treatment (MAT) and Opioid Treatment Program (OTP) FAQ (PDF)
- CDC Guideline Infographic (PDF) Download CDC Guideline Infographic (PDF)
- CDC Guidelines Factsheet (PDF) Download CDC Guidelines Factsheet (PDF)
- TurnTheTide Pocket Guide for Prescribing Opioids for Chronic Pain (PDF) Download TurnTheTide Pocket Guide for Prescribing Opioids for Chronic Pain (PDF)
- Clinical Pocket Guide to Tapering (PDF) Download Clinical Pocket Guide to Tapering (PDF)
- Tapering Resource-AAFP (PDF) Download Tapering Resource-AAFP (PDF)
- Opioid Tapering Resource pack (PDF) Download Opioid Tapering Resource pack (PDF)
- Medication Assisted Treatment (MAT) for Substance Abuse (PDF) Download Medication Assisted Treatment (MAT) for Substance Abuse (PDF)
- UDT for monitoring opioid therapy-AAFP (PDF) Download UDT for monitoring opioid therapy-AAFP (PDF)
X-Waiver
- X-Waiver resources
1. Removal of DATA Waiver (X-Waiver) Requirement
2. All prescriptions for buprenorphine will now only require a standard DEA registration number. For additional information on the removal of the DATA-Waiver requirement, see the
Practice Optimization
Electronic Prescribing (e-Rx)
Electronic prescribing is a growing standard in the healthcare industry. Most electronic health record systems offer electronic prescription capabilities. The information below will provide insight to the practice of e-prescribing.
- Benefits of e-Rx brochure (PDF) Download Benefits of e-Rx brochure (PDF)
Formulary Utilization
The IEHP Formulary offers a variety of drugs based on safety and efficacy for any condition. The information below will help you find out how to access and interpret the formulary
- Medicare FAQ (PDF) Download Medicare FAQ (PDF)
For any questions regarding Pharmacy Academic Detailing please contact:
PharmacyAcademicDetailing@iehp.org
Information on this page is current as of January 1, 2022
You will need Adobe Acrobat Reader 6.0 or later to view the PDF files. Click here to download a free copy by clicking Adobe Acrobat Reader.